Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing

Recently, it has become increasingly evident that fracture healing involves a complex interaction of many local and systemic regulatory factors. The roles of some of these growth factors have been described; however, little is understood about the presence of the bone morphogenetic proteins in fracture repair, despite the fact that they are the most potent osteoinductive proteins known. This study defines and characterizes the physiologic presence, localization, and chronology of the bone morphogenetic proteins in fracture healing with an established rat fracture healing model. With use of a recently developed monoclonal antibody against bone morphogenetic proteins 2 and 4 developed with standard avidin‐biotin complex/immunoperoxidase protocols, frozen undecalcified fracture calluses were analyzed semiquantitatively for the percentage of various types of fracture cells staining positively. During the early stages of fracture healing, only a minimum number of primitive cells stained positively in the fracture callus. As the process of endochondral ossification proceeded, the presence of bone morphogenetic proteins 2 and 4 increased dramatically, especially in the primitive mesenchymal and chondrocytic cells. While the cartilaginous component of the callus matured with a concomitant decrease in the number of primitive cells, there was a concomitant decrease in both the intensity and the number of positively staining cells. As osteoblasts started to lay down woven bone on the chondroid matrix, these osteoblastic cells exhibited strong positive staining. The intensity of this staining decreased, however, as lamellar bone replaced the primitive woven bone. A similar observation was noted for the areas of the callus undergoing intramembranous ossification. Initially, within several days after the fracture, periosteal cells and osteoblasts exhibited intense staining for bone morphogenetic proteins 2 and 4. As the woven bone was replaced with mature lamellar bone, this staining decreased. These data, and the awareness of the strong osteoinductive capacities of bone morphogenetic protein, suggest that bone morphogenetic proteins 2 and 4 are important regulators of cell differentiation during fracture repair.

[1]  O. Jungo A new diagnostic test for carpal tunnel syndrome. , 1992, The Journal of bone and joint surgery. American volume.

[2]  A. Huvos,et al.  Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewing's Sarcoma of Bone , 1992, The American journal of surgical pathology.

[3]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[5]  Y. Hoshino,et al.  Immunohistochemical Demonstration of Bone Morphogenetic Protein‐2 and Transforming Growth Factor‐β in the Ossification of the Posterior Longitudinal Ligament of the Cervical Spine , 1992, Spine.

[6]  C. Borner,et al.  c-myc protein distribution. Neoplastic tissues of the human colon. , 1992, The American journal of pathology.

[7]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[8]  N. Cunningham,et al.  Recent progress in bone induction by osteogenin and bone morphogenetic proteins: challenges for biomechanical and tissue engineering. , 1991, Journal of biomechanical engineering.

[9]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Old,et al.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Bolander,et al.  Role of Transforming Growth Factor‐β in Fracture Repair , 1990 .

[12]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[13]  M. Bolander,et al.  Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Sporn,et al.  Transforming growth factor-beta. Multiple actions and potential clinical applications. , 1989, JAMA.

[16]  J. Connolly,et al.  Development of an osteogenic bone-marrow preparation. , 1989, The Journal of bone and joint surgery. American volume.

[17]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[18]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[19]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[21]  J. Triffitt Initiation and enhancement of bone formation. A review. , 1987, Acta orthopaedica Scandinavica.

[22]  A. Burstein,et al.  The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. , 1984, The Journal of bone and joint surgery. American volume.

[23]  A. Reddi,et al.  Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[25]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[27]  M. Urist,et al.  The bone induction principle. , 1967, Clinical orthopaedics and related research.

[28]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[29]  A. Huvos,et al.  Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody , 1994, Cancer.

[30]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[31]  V. Rosen,et al.  Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. , 1989, Connective tissue research.

[32]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.